#IL23
Starla 🦮
Baby female Mixed Breed
Adoptable from Hinsdale Humane Society (Hinsdale, IL)

https://www.petfinder.com/dog/starla-77704431/il/hinsdale/hinsdale-humane-society-il23/
August 9, 2025 at 1:15 PM
Maybe we should do the IL17 and IL23 Mendelian randomisation analyses next @gushamilton.bsky.social @gpollara.bsky.social ?
December 5, 2024 at 12:30 PM
Introducing a special friend in need of a loving home: Kiriko C20837, located in Hinsdale, IL.

Learn more: https://www.petfinder.com/cat/kiriko-c20837-74208546/il/hinsdale/hinsdale-humane-society-il23/
December 28, 2024 at 4:30 AM
Better half worked on the approval of J&J #icotrokinra. Happy birthday to Icotyde! My 11 year old made this card! #psoriasis #medicine #drugs #chemistry #IL23
March 18, 2026 at 11:31 PM
And also that bizarre paradox that the biologic drugs used to treat autoimmune diseases like TNFa blockers, IL1b, IL17, IL23 blockers.... have also all been correlated to some extent with new onset autoimmune disease. Is this through increased infections?
1/ A long standing paradox in my mind (from always seeing immune "strength" or reactivity drawn as a spectrum from immunodeficiency to autoimmunity) was resolved this year at #AAI #Immunology2025. WHY do SO many people have both simultaneously? Each infection brings risk of developing autoimmunity!!
May 12, 2025 at 1:23 AM
*Tubular Bells* Plays In Background

IL23
2025

#fog #ILWx
#fotografia #photography #fotografie
December 28, 2025 at 5:30 PM
Really enjoyed working on this review for Frontline Gastroenterology. How do anti-IL23 therapies work? What’s the evidence for their use in IBD? And is there any guidance on how we should position them in the treatment landscape?

fg.bmj.com/content/earl...
January 17, 2025 at 11:15 AM
Fable 🐾
Adult male Mixed Breed
Adoptable from Hinsdale Humane Society (Hinsdale, IL)

https://www.petfinder.com/dog/fable-78284597/il/hinsdale/hinsdale-humane-society-il23/
September 16, 2025 at 1:15 PM
Guselkumab in mod-severe Crohn's disease

- anti-p19 (IL23)
- GALAXI 2 & 3 Phase 3 RCTs
- effective and safe
- superior to placebo and ustekinumab

#IBDSky
@amcollegegastro.bsky.social
November 15, 2024 at 12:03 PM
I think the tl:dr (using my dusty old biomedical science degree to dig a bit) is they found more specific targets for therapy and this is the waves of monoclonal antibody therapies targeting those targets (namely IL17 and IL23) coming to market
March 10, 2025 at 4:04 AM
Wilson 🐕
Adult male Mixed Breed
Adoptable from Hinsdale Humane Society (Hinsdale, IL)

https://www.petfinder.com/dog/wilson-77378401/il/hinsdale/hinsdale-humane-society-il23/
July 19, 2025 at 10:00 PM
Phoebe 🐾
Baby female Mixed Breed
Adoptable from Hinsdale Humane Society (Hinsdale, IL)

https://www.petfinder.com/dog/phoebe-77612174/il/hinsdale/hinsdale-humane-society-il23/
August 3, 2025 at 11:45 AM
Step
YouTube video by Miyumin - Topic
www.youtube.com
February 5, 2026 at 2:23 PM
RRIDs were included in this in JCI Insight paper. Thanks for making your methods matter! #methodsmatter #RRID #reproducibility
Enhancing IgG fragment crystallisable sialylation improves the therapeutic activity of IL23 cytokine blockade
Read the full paper: Enhancing IgG fragment crystallisable sialylation improves the therapeutic activity of IL23 cytokine blockade
doi.org
March 13, 2026 at 7:00 AM
Subsequently, we found that anti-IL-12p35 did not help, could even make things work. In 2003, IL23 was discovered, consisting of IL23p19 and IL12p40. This has an important role in chronic immune disorders. Here the antibody against IL23p23 is trialed against Crohn´s disease.
3/6
November 25, 2024 at 11:24 AM
Introducing a special friend in need of a loving home: Odin 1665, located in Hinsdale, IL.

Learn more: https://www.petfinder.com/dog/odin-1665-70130469/il/hinsdale/hinsdale-humane-society-il23/
Introducing a special friend in need of a loving home: Odin 1665, located in Hinsdale, IL. Learn more: https://www.petfinder.com/dog/odin-1665-70130469/il/hinsdale/hinsdale-humane-society-il23/
dlvr.it
April 14, 2024 at 6:33 AM
Cytokine profiling identifies circulating IL-2, IL23 and sPD-L1 as prognostic biomarkers for treatment outcomes in Non-Small cell Lung Cancer patients undergoing anti-PD1 therapy https://www.biorxiv.org/content/10.1101/2025.05.13.653410v1
May 14, 2025 at 12:50 PM
💊#FDAApproval Update | The FDA has approved a label expansion for #TREMFYA (#guselkumab), making it the only IL23 inhibitor proven to help inhibit progression of structural joint damage in active psoriatic arthritis (#PsA).
Phase3b APEX trial:
✔️A 57% decrease in the rate of radiographic progression
May 29, 2026 at 2:02 PM